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SUMMARY
Stress granule (SG) formation is frequently accompanied by ubiquitin proteasome system (UPS) 
impairment and ubiquitylated protein accumulation. SGs, ubiquitin, and UPS components co-
localize, but the relationship between the ubiquitin pathway and SGs has not been systematically 
characterized. We utilize pharmacological inhibition of either the ubiquitin- or NEDD8-activating 
enzyme (UAE or NAE) to probe whether active ubiquitylation or neddylation modulate SG 
dynamics. We show that UAE inhibition results in rapid loss of global protein ubiquitylation using 
ubiquitin-specific proteomics. Critically, inhibiting neither UAE nor NAE significantly affected 
SG formation or disassembly, indicating that active protein ubiquitylation or neddylation is 
dispensable for SG dynamics. Using antibodies with varying preference for free ubiquitin or 
polyubiquitin and fluorescently tagged ubiquitin variants in combination with UAE inhibition, we 
show that SGs co-localize primarily with unconjugated ubiquitin rather than polyubiquitylated 
proteins. These findings clarify the role of ubiquitin in SG biology and suggest that free ubiquitin 
may alter SG protein interactions.
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Graphical Abstract
In Brief
Protein ubiquitylation has been implicated in pathways by which cellular stress induces the 
formation of stress granules (SGs) and affects protein homeostasis through the ubiquitin 
proteasome system. Markmiller et al. show that ubiquitylation is dispensable for SG dynamics and 
that SGs co-localize primarily with free ubiquitin rather than polyubiquitylated proteins.
INTRODUCTION
Cellular insults such as oxidative and heat stress that globally disrupt protein folding result 
in both the accumulation of ubiquitylated proteins and the induction of membrane-less stress 
granules (SGs) (Kim et al., 2015; Protter and Parker, 2016). SGs are enigmatic cellular 
structures that comprise translationally repressed mRNAs associated with a variety of RNA-
binding proteins (Buchan, 2014). While the cellular function of SGs remains unclear, SG 
formation and SG resident proteins have been linked to human neurological disorders, 
including amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) 
(Buchan, 2014; Dewey et al., 2012; Li et al., 2013). Genomic and proteomic characterization 
of both the SG RNA and protein constituents have revealed a marked compositional 
diversity in both SG proteins and RNAs (Jain et al., 2016; Khong et al., 2017; Markmiller et 
al., 2018). Examination of SG proteomes has revealed that proteins involved in regulating 
distinct post-translational modifications (PTMs) are often enriched within SGs. These 
findings suggest that PTMs may regulate either global SG dynamics or the recruitment of 
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individual proteins into SGs and that targeting PTMs may be an effective strategy to alter SG 
dynamics (Ohn and Anderson, 2010).
Numerous lines of evidence have implicated protein ubiquitylation or other ubiquitin-like 
modification systems, like neddylation, as potential regulators of SG dynamics. First, 
components of the ubiquitin-proteasome system (UPS), including ubiquitin itself, have been 
shown to co-localize with SGs induced by a variety of protein homeostasis stressors (Kwon 
et al., 2007; Mateju et al., 2017; Xie et al., 2018). Second, proteasome inhibition and the 
concomitant increase in polyubiquitylated proteins results in SG formation (Mateju et al., 
2017; Mazroui et al., 2007; Seguin et al., 2014). Third, genetic disruption or 
pharmacological inhibition of ubiquitin or neddylation components can disrupt SG dynamics 
in both S. cerevisiae and mammalian cells (Buchan et al., 2013; Jayabalan et al., 2016; 
Kwon et al., 2007; Ohn et al., 2008; Seguin et al., 2014; Takahashi et al., 2013; Turakhiya et 
al., 2018; Xie et al., 2018). Despite this evidence, several key questions regarding the role of 
ubiquitylation in regulating SG dynamics remain unanswered. While ubiquitin has been 
shown to co-localize with SGs, whether polyubiquitylated proteins them-selves or proteins 
modified with specific ubiquitin linkages are recruited to SGs is unknown. It is also 
unknown how many of the ubiquitin-system components that co-localize with SGs require 
ubiquitin within SGs for their localization. The deubiquitylating enzyme USP10 is a well-
characterized SG-localized protein (Ohn et al., 2008; Soncini et al., 2001). However, USP10 
SG localization is determined by binding to another SG protein, G3BP1; and mutation of the 
UPS10 active site, which renders it incapable of removing ubiquitin from substrates, had 
little impact on its localization or overall SG dynamics (Kedersha et al., 2016; Takahashi et 
al., 2013). Despite the many links between the UPS and SGs, there has yet to be a 
demonstration that ubiquitylation of a specific SG protein is required for its SG localization 
or that overall protein ubiquitylation or other ubiquitin-like protein modification pathways 
are needed to form or dissolve SGs.
Here, we directly examine the relationship between protein ubiquitylation and SG dynamics. 
Interrogation of global protein ubiquitylation using ubiquitin proteomics approaches 
revealed widespread alterations to the ubiquitin-modified proteome upon arsenite-induced 
stress. Despite clear changes to some SG protein ubiquitylation, arsenite treatment did not 
result in global changes to known SG-resident protein ubiquitylation. Utilizing potent and 
specific inhibitors of either the ubiquitin-activating enzyme (UAE) or the NEDD8-activating 
enzyme (NAE), we demonstrate that active protein ubiquitylation or neddylation is 
dispensable for arsenite-induced SG formation or dissolution. We demonstrate that free, 
unconjugated ubiquitin localizes to SGs in a UAE-independent manner. Further, the SG 
localization of many ubiquitin system components is similarly unperturbed by UAE 
inhibition and the concomitant ablation of protein ubiquitylation. Taken together, our results 
clearly demonstrate that active protein neddylation or ubiquitylation is not required for SG 
dynamics and that unconjugated ubiquitin is the primary form of ubiquitin that localizes to 
SGs.
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RESULTS
Identification of Resident SG Protein Ubiquitylation upon Arsenite Treatment
Sodium arsenite is one of the most robust known inducers of transient SGs that form rapidly 
and disperse within 2–3 h upon washout (Figures S1A and S1B). Arsenite-induced SG 
formation coincides with eIF2a phosphorylation and a global increase in ubiquitylated 
proteins (Figures 1A, S1C, and S1D). These results demonstrate that the timing of 
alterations to protein ubiquitylation largely mirrors SG dynamics, indicating a possible role 
for protein ubiquitylation during SG for mation or dissolution. To identify proteins whose 
ubiquitylation may be critical for their SG localization, we utilized quantitative ubiquitin 
site-specific proteomic approaches to identify proteins whose ubiquitylation status was 
altered upon arsenite treatment (Gendron et al., 2016; Kim et al., 2011). HeLa cells grown in 
media containing 13C15N-labeled lysine were either untreated or treated with arsenite for 20 
or 45 min or were treated with arsenite for 45 min, followed by washout and recovery for 3 
h. Arsenite treatment did not result in overt changes to protein abundance, at least for the 
depth of proteome coverage achieved in this experiment. However, consistent with our 
previous results, arsenite treatment resulted in a global increase in protein ubiquitylation, 
which was reduced upon arsenite removal (Figures 1A and 1B; Table S1). In cells treated 
with arsenite for 45 min, greater than 35% of all quantified ubiquitin-modified peptides 
increased or decreased in abundance more than 2-fold, indicating that a significant fraction 
of protein ubiquitylation is impacted by arsenite treatment (Figure 1C). Modest, but 
consistent abundance increases in all but lysine 11 (K11)-linked ubiquitin chains were 
observed upon 45-min arsenite treatment (Figure 1D). To directly examine whether known 
SG proteins were selectively ubiquitylated upon arsenite treatment (Table S2), we quantified 
a total of 102 ubiquitylated peptides from 43 proteins from a curated list of validated SG 
resident proteins. We found no significant difference in the abundance of these peptides 
upon arsenite treatment or washout compared to untreated samples, indicating that, at a 
global level, SG resident protein ubiquitylation was not specifically altered during 
conditions that induce SG formation (Figure 1E; Table S2). While our data suggest that SG 
protein ubiquitylation is not globally impacted by arsenite treatment, it does not rule out the 
possibility that the ubiquitylation of specific SG proteins governs their SG localization.
Acute Pharmacological UAE Inhibition Results in a Rapid Loss of Protein Ubiquitylation
Ubiquitin has been observed to co-localize with SGs, and ubiquitin system components have 
been demonstrated to both localize to SGs and regulate SG dynamics, implicating a role for 
protein ubiquitylation during SG formation or dissolution (Buchan et al., 2013; Kwon et al., 
2007). However, a direct evaluation of whether active protein ubiquitylation is required to 
either form or resolve SGs has not been reported. To perform such an examination, we 
utilized a specific and potent ubiquitin E1 activating enzyme (UAE) inhibitor (TAK-243, 
also known as MLN7243, which we refer to as Ub-E1i) to acutely inhibit protein 
ubiquitylation (Hyer et al., 2018). The addition of increasing amounts of UbE1i to HCT116 
cells for 4 h resulted in a dose-dependent decrease in polyubiquitylated proteins, with 
complete abrogation of observable polyubiquitylated material with Ub-E1i treatment above 
0.5 μM (Figure 2A). Proteasome inhibition by MG132 resulted in the well-characterized 
increase in total protein ubiquitylation, which was completely blocked upon co-treatment 
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with Ub-E1i. The addition of Ub-E1i resulted in a time-dependent decrease in 
polyubiquitylated material. Consistent with previous reports, Ub-E1i treatment was selective 
for UAE, as cullin neddylation was unaffected after 4 h of Ub-E1i treatment but was 
completely blocked by addition of the NAE inhibitor MLN4924 (TAK-924, which we refer 
to as N8-E1i) (Figures 2A and 2B) (Soucy et al., 2009). We next set out to establish the 
impact of Ub-E1i inhibition on individual protein ubiquitylation using quantitative, ubiquitin 
site-specific proteomics. Heavy (13C15N) lysine-labeled HCT116 cells were treated with Ub-
E1i alone or in combination with MG132 for 4 h and then mixed with unlabeled HCT116 
cells that were either untreated or treated with MG132. As expected, Ub-E1i treatment 
resulted in a robust reduction in the abundance of the clear majority of ubiquitylated 
peptides identified (Table S3). More than 80% of all quantified ubiquitin-modified peptides 
were reduced in abundance by more than 1.7-fold with or without MG132 treatment 
(Figures 2C and 2D). As had previously been observed upon treatment with proteasome 
inhibitors (Gendron et al., 2016; Kim et al., 2011), UAE inactivation had little impact on 
overall protein abundance after 4 h of treatment (Figure 2C; Table S3). However, a more 
complete characterization of low abundance proteins would likely reveal robust protein 
abundance alterations. As would be predicted upon UAE inhibition, all detected ubiquitin-
linkage peptides were reduced more than 8-fold, indicating that Ub-E1i treatment reduces 
total protein polyubiquitylation, regardless of chain type (Figure 2E). A direct examination 
of the ubiquitylation status of known SG proteins revealed that Ub-E1i treatment resulted in 
a clear reduction of SG protein ubiquitylation across a diversity of individual ubiquitylation 
sites (Figure 2F; Table S2). Our results demonstrate that Ub-E1i treatment results in the 
rapid loss of more than 80% of all ubiquitylation events.
Active Protein Ubiquitylation or Neddylation Is Not Required for SG Formation or 
Dissolution
Having established UAE inactivation via Ub-E1i treatment as a powerful tool to rapidly and 
robustly ablate protein ubiquitylation, we set out to test whether SG formation or dissolution 
requires protein ubiquitylation. We validated that Ub-E1i treatment ablated the arsenite-
induced increase in protein polyubiquitylation in three cell lines (Figure S2A). We utilized a 
previously characterized 293T cell line expressing the well-established SG protein, G3BP1, 
tagged with GFP at its endogenous C terminus using CRISPR/Cas9-based approaches 
(Markmiller et al., 2018) to track SG dynamics. Consistent with previous results, arsenite 
addition resulted in a rapid increase in SG formation, as determined by G3BP1-GFP 
coalescence (Figures 3A and 3B). Pre-treatment with Ub-E1i followed by treatment with 
two different concentrations of arsenite did not delay the kinetics of SG formation over a 2-h 
time course (Figures 3A, 3B, S2B, and S2C). Although Ub-E1i treatment has been reported 
to induce the unfolded protein response (UPR) (Best et al., 2019; Hyer et al., 2018; Zhuang 
et al., 2019), the addition of either Ub-E1i or N8-E1i alone did not induce SG formation 
(Figure S2B). However, Ub-E1i pre-treatment resulted in a small enhancement of SG 
formation at early time points, with lower concentrations of arsenite (100 μM), indicating 
that the added stress of UAE inhibition may accelerate SG formation under these conditions. 
Pre-treatment with the NAE inhibitor MLN4924 (N8-E1i), followed by arsenite treatment, 
did not affect SG formation at either of the tested arsenite concentrations (Figures 3A, 3B, 
S2B, and S2C). Taken together, these observations indicate that neither active protein 
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ubiquitylation nor neddylation is required for initial arsenite-induced SG formation. We then 
determined whether protein ubiquitylation or neddylation was required for SG dissolution 
following arsenite removal. 293T G3BP1-GFP cells were pre-treated with DMSO, Ub-E1i, 
or N8-E1i for 1 h, and SGs were formed by treatment with arsenite in the presence of 
inhibitors for 1 h. SG dissolution was monitored after arsenite washout in media that lacked 
Ub-E1i or N8-E1i. While NAE inhibition has no measurable impact on SG dissolution, the 
addition of Ub-E1i resulted in a minor delay in SG dissolution (Figures 3C and 3D). We 
validated these results in HeLa cells using G3BP1 antibodies to monitor SG formation and 
clearance. As observed in 293T cells, UAE inhibition did not delay the kinetics of arsenite-
induced SG formation using two different arsenite concentrations, with a slight acceleration 
of SG formation at early time points (Figures 3E, 3F, and S2D). We were unable to validate 
the small delay in SG dissolution upon the Ub-E1i treatment seen in 293T cells, as UAE 
inactivation had no impact on SG clearance in HeLa cells (Figures 3G, 3H, and S2E). It is 
possible that SG composition may change during longer exposures to stress and that features 
including the content and function of ubiquitin may be more relevant upon longer stress 
treatments. Therefore, we analyzed SG dynamics following longer arsenite treatment in 
HeLa cells (3 h at 250 μM) and found disassembly kinetics to be similarly unaffected by 
UAE inhibition (Figure S2F). Since UAE and NAE inhibition by Ub-E1i or N8-E1i is 
reversible in nature, it is possible that gradual enzyme reactivation could occur during SG 
dissolution. To address this issue, we examined the recovery of protein neddylation and 
ubiquitylation after pre-treatment of the E1 inhibitors and subsequent arsenite treatment 
followed by washout conditions with or without E1 inhibitors. In 293T cells, protein 
ubiquitylation and cullin neddylation were restored to ~20% of pre-treatment levels 5 h after 
E1 inhibitor removal (Figures S3A–S3D). By contrast, in HeLa and HCT116 cells, the 
extent of ubiquitylation and neddylation recovery after washout was greatly reduced, with no 
observable recovery of protein ubiquitylation in HeLa cells 5 h after Ub-E1i washout 
(Figures S3E and S3F). Notably, SG disassembly was complete in HeLa cells after 5 h, 
indicating that SG disassembly is not dependent on recovery of UAE activity during the 
washout phase. Consistent with this finding, the addition of Ub-E1i during the washout 
period did not delay SG dissolution following arsenite removal (Figure S3G). Taken 
together, our results clearly indicate that acute inhibition of protein ubiquitylation or 
neddylation has little to no impact on SG dynamics.
Unconjugated Ubiquitin Co-localizes with SGs in a UAE-Independent Manner
In accordance with previous studies, we were able to show that ubiquitin co-localizes with 
SGs by immunofluorescence (IF), using an antibody that recognizes both free and 
conjugated ubiquitin (Figures 4A and S2A). Because ubiquitin exists in a variety of bio-
chemically distinct pools within cells (e.g., unconjugated, free ubiquitin, and lysine-48 
linked polyubiquitin chains) (Clague et al., 2015), we set out to carefully characterize which 
forms of ubiquitin specifically co-localize with SGs. Staining with two different ubiquitin 
antibodies that preferentially recognize polyubiquitin chains under denaturing PAGE-
western blotting conditions did not reveal any significant co-localization of polyubiquitin 
with SGs in HeLa cells (Figures 4B and S4A–S4C) (Fujimuro and Yokosawa, 2005), 
indicating that polyubiquitylated proteins are not enriched within SGs. This hypothesis is 
further supported by the finding that K48- or K63-linkage-specific antibodies (Apu2 and 
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Apu3, respectively) also do not recognize antigens that co-localize with arsenite-induced 
SGs (Figures 4B and S4C). Instead, the IF staining signals from both K48- and K63-specific 
antibodies, as well as from the polyubiquitin-specific FK1 and FK2 antibodies, all appear 
enriched at a single perinuclear focus per cell, suggesting a partial compartmentalization of 
polyubiquitylated proteins outside of SGs during stress (Figures 4B and S4C). Underscoring 
the specificity of the IF signals obtained with the FK1, FK2, Apu2, and Apu3 antibodies, 
overall staining intensity was drastically reduced upon Ub-E1i treatment, consistent with the 
observed depletion of polyubiquitin chains after Ub-E1i treatment by western blotting 
(Figures 4B and S4A–S4C). By contrast, IF staining with the pan-ubiquitin antibody did not 
prominently label the same foci as observed with the poly-ubiquitin antibodies (Figures 4A 
and S4C), and overall signal intensity was slightly increased, while SG staining was 
unchanged upon Ub-E1i treatment. These results indicate that primarily free, unconjugated 
ubiquitin localizes to arsenite-induced SGs.
To validate these findings, we generated HeLa cell lines that stably expressed either 
mCherry-tagged wild-type ubiquitin (mCh-Ub-WT) or mCherry-tagged ubiquitin in which 
all internal lysine residues were mutated to arginine and the C-terminal di-glycine residue 
was removed (mCh-Ub-K0ΔGG). The K0DGG variant is unable to be incorporated into 
chains or be utilized by the ubiquitin conjugation machinery, thus serving as a marker for 
free ubiquitin (Dantuma et al., 2006). Recapitulating the results obtained by IF staining, 
mCh-Ub-WT strongly localized to a single perinuclear focus per cell, with no observable SG 
co-localization upon arsenite treatment (Figure 4C). When cells were treated with Ub-E1i 
prior to and during stress as described earlier, these large foci were largely ablated, and some 
co-localization with SGs was observed (Figure 4C). By contrast, mCh-Ub-K0ΔGG localized 
to SGs in a Ub-E1i-independent manner and did not accumulate in larger foci distinct from 
SGs. (Figure 4C). We obtained the same results in 293T cells stably expressing mCherry-
tagged ubiquitin variants (Figure S4D). In summary, our data demonstrate that free ubiquitin 
is the primary form of ubiquitin that localizes to arsenite-induced SGs.
Polyubiquitin Accumulates at Centrosomes in Response to Stress
We next sought to characterize the structures at which we observed the accumulation of 
polyubiquitylated proteins in response to arsenite stress. Their subcellular localization was 
highly reminiscent of the centrosome, which has been implicated in the proteasomal 
processing of ubiquitylated substrates (Fabunmi et al., 2000; Wigley et al., 1999). Indeed, IF 
staining showed clear co-localization of the polyubiquitin signal with the centrosomal 
marker pericentrin (PCNT), as well as proteasome subunits (Figure 4D). Treatment of cells 
with Ub-E1i did not affect localization of PCNT or the proteasome, indicating that 
polyubiquitin is not essential for scaffolding or maintaining the centrosome-associated 
proteasome.
Localization of UPS Proteins Does Not Depend on Polyubiquitin
In light of these findings, we further characterized the effect of ablating polyubiquitylation 
on the subcellular distribution of several proteins associated either with stress-induced 
protein homeostasis or with otherwise known or proposed functions within the UPS. 
Strikingly, of the proteins we analyzed, only the localization of the autophagy-related 
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protein sequestosome-1 (SQSTM/p62) was affected upon Ub-E1i treatment, losing its 
punctate appearance in what are likely to be previously described p62-positive deposition 
sites (Ganassi et al., 2016; Minoia et al., 2014) (Figure 4E). By contrast, localization of 
VCP/p97 was unchanged upon UAE inhibition, as was the SG localization of previously 
characterized SG-localized UPS components HDAC6, BAG3, TRIM25, and UBAP2L 
(Ganassi et al., 2016; Kwon et al., 2007; Markmiller et al., 2018) (Figure 4E). These 
findings are consistent with our hypothesis that protein ubiquitylation is dispensable for SG 
formation by showing that even proteins with demonstrated functions within the UPS 
associate with SGs in a UAE-independent manner.
DISCUSSION
Accumulating evidence suggests that multivalent protein-protein, protein-RNA, and RNA-
RNA interactions are required to nucleate SGs and that SGs form as a result of liquid-liquid 
phase separation (LLPS) among SG components (Van Treeck and Parker, 2018; Wheeler et 
al., 2016). Indeed, many identified SG proteins contain intrinsically disordered domains or 
domains of low complexity that are critical not only for their SG localization but also for 
their ability to undergo phase transitions in vitro (Boeynaems et al., 2017; Lin et al., 2015; 
Mackenzie et al., 2017; Martinez et al., 2016; Molliex et al., 2015; Murakami et al., 2015; 
Patel et al., 2015; Riback et al., 2017; Xiang et al., 2015). Post-translational modifications 
on SG proteins could serve to either disrupt critical multivalent interactions or provide new 
contact surfaces that drive LLPS (Ohn and Anderson, 2010). Because ubiquitin can form 
polymeric chains and ubiquitin-inter-acting proteins are present in SGs, it was conceivable 
that protein ubiquitylation might regulate higher order protein-protein interactions critical 
for SG dynamics. Combined with previous studies, our results demonstrate that ubiquitin co-
localizes with SGs nucleated in response to oxidative stress caused by sodium arsenite 
treatment. However, our results also clearly establish that acute inhibition of active protein 
ubiquitylation or neddylation does not directly impact SG formation or dissolution, despite 
the near ablation of overall protein ubiquitylation.
We show that the SG localization of several proteins associated with the UPS is equally 
unaffected by UAE inhibition, supporting the notion that polyubiquitin plays, at most, a 
minor role in SG biology. Nevertheless, a systematic characterization of SG composition 
under Ub-E1i treatment conditions would determine whether any proteins require active 
ubiquitylation for their SG localization. Our observation that ubiquitin remains detectable 
within SGs even after acute UAE inhibition could simply be the result of free ubiquitin 
localizing to SGs in a passive manner. Alternatively, it is possible that free, unconjugated 
ubiquitin may play a role in nucleating or modulating SGs. Consistent with this hypothesis is 
the demonstration that the ubiquitin-binding protein UBQLN2 undergoes LLPS in vitro and 
that this transition can be inhibited by adding unconjugated ubiquitin to the reaction (Dao et 
al., 2018). It will be difficult to demonstrate that free ubiquitin is critical for SG dynamics, 
given the inability to ablate cellular ubiquitin without catastrophic consequences to overall 
cellular function.
Nearly all chemical SG inducers disrupt protein folding and quality control pathways, 
resulting in the accumulation of polyubiquitylated material within cells. While our data 
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show that polyubiquitylation is not a critical factor in the acute formation and disassembly of 
SGs, it is likely to be important in determining how the SG response is integrated with the 
larger proteostasis system during stress. However, the type and extent of cellular stress will 
need to be carefully controlled to make definitive links between proteostasis dysfunction and 
SG dynamics. For example, previous studies demonstrated that long-term (18-h) NAE 
inhibition or knockdown of neddylation components inhibits SG formation (Jayabalan et al., 
2016; Ohn et al., 2008). Near-complete NAE inhibition using N8-E1i takes place on minute 
timescales when added to mammalian cells (Liu et al., 2018). As such, it is critical to 
separate observations using acute NAE or UAE inhibition from those using prolonged 
inhibition that will result in widespread cellular dysfunction. Clear temporal studies 
investigating SG compositional dynamics over long timescales during conditions that 
promote proteostasis dysfunction are needed to provide insight into how the proteostasis 
machinery, like the UPS, interact and cooperate with SGs during disease pathogenesis.
STAR⋆METHODS
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Eric J. Bennett (e1bennett@ucsd.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Immortalized human cell lines were utilized in this study. The Lenti-X HEK293T cell line is 
derived from human female tissue, the HCT116 cell line is derived from human colorectal 
carcinoma tissue, and HeLa S3 cells are derived from human female cervical 
adenocarcinoma tissue. All cell lines were grown in complete DMEM media (GIBCO) 
supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37°C in a 
humidified incubator under 5% CO2.
METHOD DETAILS
SILAC labeling—For stable isotope labeling by amino acids in cell culture (SILAC) 
experiments, cells were cultured in custom DMEM without arginine or lysine (Mediatech) 
supplemented with 10% dialyzed FBS (Life Technologies), 1% penicillin/streptomycin, L-
Arginine hydrochloride (85mg/ml Sigma) and either “light” L-Lysine hydrochloride 
(50μg/ml Sigma) or heavy 13C6,15N2 L-Lysine-hydrochloride (50mg/ml Cambridge 
Isotopes) and 292 mg/mL L-Glutamine (Mediatech).
Mass Spectrometry—Heavy and light labeled cells were mixed 1:1 and processed for 
proteomics and diGLY-immuno-affinity enrichment as described previously(Gendron et al., 
2016; Kim et al., 2011). Samples were analyzed by LC-MS/MS using a Q-Exactive mass 
spectrometer (Thermo Scientific, San Jose, CA) and all data was processed as described 
previously (Gendron et al., 2016). All RAW mass spectrometry data files have been 
deposited at the MassIVE repository using the accession identifier MassIVE: 
MSV000082933.
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Generation of cell lines stably expressing mCherry-tagged ubiquitin—For 
creation of stable cell lines, we generated a MSCV-N-mCherry-IRES-PURO gateway 
destination vector by replacing the Flag-HA cassette from MSCV-N-Flag-HA-IRES-PURO 
(Addgene #41033) with mCherry. Wild-type ubiquitin (Ub-WT) and ubiquitin in which all 
internal lysine residues were mutated to arginine and the c-terminal diglycine residues were 
removed (Ub-K0ΔGG) were cloned into the MSCV-N-Flag-HA-IRES-PURO retroviral 
vector by gateway cloning. Retrovirus was packaged in 293 Lenti-X cells (Clontech/
TaKaRa) according to standard procedures. HeLa and 293T cells were transduced with 
retroviral particles and polyclonal cell lines with stable expression of mCherry-Ub variants 
established by puromycin selection.
Immunofluorescence, imaging and image analysis—For immunofluorescence 
experiments, cells were plates into 96- or 384-well optical bottom plates and left to adhere 
for 24–28 hours. After inhibitor and stress treatments, cells were fixed in 4% 
paraformaldehyde in PBS or PHEM buffer (60mM PIPES, 25mM HEPES, 4mM MgCl2, 
10mM EGTA, pH 7.4) for 15–20’ at room temperature, permeabilized in 0.25% Triton-X in 
PBS for 15’ at RT, followed by blocking in 2% BSA + 10% normal goat serum in PBS 
+ 0.01% Tween-20 (PBST) and 0.3M glycine for at least 60min at RT. Primary antibodies 
were diluted in 1× PHEM buffer + 1% BSA + 5% normal goat serum and incubated either at 
RT for 1–4 hours or overnight at 4°C. After 2 washes in PBST, cells were incubated with 
secondary antibodies in PBST + DAPI for 30–60min at RT, followed by two washes in 
PBST and final resuspension in 50% glycerol in PBS. Cells were then imaged either at 20× 
or 40× magnification on a ZEISS Axio Vert.A1 inverted microscope with equipped with a 
Colibri LED light source and Apotome optical sectioning module. Images were processed in 
ImageJ.
High-content imaging of SG time course plates—96- or 384-well plates were 
imaged using a Vala Sciences IC200-KIC high-content screening system. Either four or nine 
fields at the center of each well were imaged with a 20× objective through 460 nm and 535 
nm emission filters for DAPI and G3BP1-GFP, respectively. Exposure times were optimized 
for each set of plates and applied uniformly to all wells.
QUANTIFICATION AND STATISTICAL ANALYSIS
Automated image segmentation and feature quantification—Images from SG 
assembly and disassembly time courses were segmented and image features identified and 
quantified using a custom CellProfiler pipeline (Carpenter et al., 2006). Briefly, nuclei were 
segmented and identified in the DAPI fluorescence channel images using a diameter cutoff 
of 9–80 pixels for HEK293xT and HeLa cells. Both nuclei count and total nuclear area were 
calculated for each image. For quantification of SGs, we first identified cell bodies by 
overlaying the GFP fluorescence channel images and tracing radially outward from the 
nuclei to the limits of the cytoplasmic G3BP1-GFP signal. The cell bodies were used as 
masks for the subsequent SG identification to eliminate imaging artifacts outside of cell 
boundaries, such as background fluorescence or dead cells. After masking, punctate 
structures within the cell body area were selected by enhancing speckle-like features that 
were 10 pixels in diameter for HEK293xT and HeLa cells, and these punctate structures 
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were then annotated as stress granules. As for nuclei, both SG count and total SG area were 
calculated for each image. We chose normalized SG area as the most robust metric for SG 
dynamics. This measure was obtained by calculating the total area covered by SGs in each 
image and normalizing this by dividing SG area by the total area covered by nuclei in the 
same image. Each experimental condition was represented by between 12 and 16 replicate 
wells, with between 4 and 9 images acquired per well. The mean and standard deviation 
were calculated across all replicate wells and fields of view acquired per well, with a 
minimum of ~25,000 cells analyzed per condition.
DATA AND SOFTWARE AVAILABILITY
The proteomics data reported in this paper are available for download from the MassIVE 
mass spectrometry data repository (https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp). 
The accession for this dataset is MassIVE: MSV000082933.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Ubiquitin-activating enzyme inhibition rapidly ablates global protein 
ubiquitylation
• Stress granule (SG) dynamics are unaffected by acute UAE or NAE inhibition
• SGs co-localize with unconjugated ubiquitin but not polyubiquitylated 
proteins
• SG-association of ubiquitin-related proteins is independent of 
polyubiquitylation
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Figure 1. SG Protein Ubiquitylation Is Largely Unaffected by NaAsO2 Treatment
(A) Immunoblot of phospho-eIF2a, ubiquitin, and tubulin in whole-cell extracts from HeLa 
cells treated with NaAsO2 as indicated. s and l denote short and long exposures, respectively.
(B) Log2 heavy-to-light ratios (log2 H/L) for all diGLY-modified peptides (top) and total 
proteins (bottom). Heavy-labeled cells were treated with NaAsO2 as indicated.
(C) The fraction of all quantified diGLY peptides with >2-fold change in abundance upon 
NaAsO2 treatment or washout.
(D) Log2 H/L corresponding to diGLY-modified peptides from ubiquitin. The individual 
ubiquitin modified lysine that was quantified is indicated. Error bars denote SEM of multiple 
quantification events for a given peptide.
(E) The median log2 H/L of all diGLY-modified peptides quantified from known SG 
proteins. Error bars denote SEM for all diGLY quantification events observed on known SG 
proteins. NS, not significant.
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See also Figure S1 and Tables S1 and S2.
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Figure 2. The Ubiquitin-Activating Enzyme Inhibitor TAK-243 Rapidly Ablates Ubiquitin 
Conjugates in Cells
(A and B) Immunoblot of Nedd8, ubiquitin, and tubulin in whole-cell extracts from HCT116 
cells treated with Ub-E1i or N8-E1i alone (A and B) or in combination with MG132 (A) as 
indicated. s and l denote short and long exposures, respectively.
(C) Log2 H/L for all diGLY-modified peptides (top) and total proteins (bottom). Heavy-
labeled cells were treated with Ub-E1i (1 μM) with or without MG132 (10 μM) for 4 h.
(D) The fraction of all quantified diGLY-modified peptides that increased, decreased, or 
remained unchanged upon Ub-E1i treatment with or without proteasome inhibition.
(E) Log2 H/L corresponding to diGLY-modified peptides from ubiquitin after Ub-E1i 
treatment alone. The individual ubiquitin-modified lysine that was quantified is indicated. 
Error bars denote SEM of multiple quantification events for a given peptide.
(F) Log2 H/L of all diGLY-modified peptides quantified from known SG proteins. Heavy-
labeled cells were treated with Ub-E1i (1 μM) with or without MG132 (10 μM) for 4 h.
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See also Tables S2 and S3.
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Figure 3. SG Dynamics Are Unaffected by Inhibition of Protein Ubiquitylation or Neddylation
(A, C, E, and G) Quantification of stress granule (SG) dynamics in 293T G3BP1-GFP (A 
and C) and HeLa (E and G) cells during SG assembly (A and E) and disassembly (C and G). 
Cells in multi-well plates were treated with inhibitors and NaAsO2 as indicated, with or 
without subsequent washout. Following fixation at the indicated time points, HeLa cells 
were immunostained with an antibody against G3BP1, and plates were imaged using an 
automated image acquisition system. SG and nuclear area were quantified using custom 
image analysis scripts, and error bars denote SD. A minimum of ~25,000 cells were 
analyzed for each cell type, condition, or time point.
(B, D, F, and H) Representative images for indicated time points and treatments quantified in 
(A),(C), (E), and (G), respectively. Scale bars, 20 μm.
See also Figures S2 and S3.
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Figure 4. Unconjugated Ubiquitin Localizes to SGs in a UAE-Independent Manner
(A–E) Immunofluorescence staining of HeLa cells treated with NaAsO2 (250 μM) for 0’, 
45’, or 120’ prior to fixation (A) or pretreated with DMSO or UbE1i (1 μ M) for 90’, 
followed by treatment with NaAsO2 (250 mM) for 120’ prior to fixation (B–E). Cells were 
stained with antibodies against G3BP1 (A–E), pan-ubiquitin (A), polyubiquitin (B and D), 
centrosome marker pericentrin (D), proteasome subunits (D), VCP/p97 (E), SQSTM/p62 
(E), HDAC6 (E), UBAP2L (E), or TRIM 25 (E). (C) Cells stably expressing either mCherry-
tagged wild-type ubiquitin (mCh-Ub-WT) or mCherry-tagged ubiquitin, in which all internal 
lysine residues were mutated to arginine and the C-terminal diglycine residues were 
removed (mCh-Ub-K0DGG [K0dGG]) were stained with antibodies against G3BP1. 
G3BP1-positive SGs are indicated by arrows (both red and white). G3BP1-negative 
perinuclear foci are indicated by solid yellow arrowheads. G3BP1-negative punctate signal 
for VCP/p97 and SQSTM/p62 is indicated by blue open arrowheads. Images from Ub-E1i-
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treated cells in all panels were taken at the same exposure time and acquisition settings in 
the ubiquitin channel as those for images from DMSO-treated cells. Nuclei were stained 
using DAPI. Scale bars, 20 μ m in all panels.
See also Figure S4.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal anti-G3BP1 MBL International Cat#RN048PW; RRID:AB_10794608
Mouse monoclonal anti-G3BP1 EMD Millipore Cat#05–1938; RRID:AB_10561767
Rabbit polyclonal anti-Ubiquitin EMD Millipore Cat#AB1690; RRID:AB_2180744)
Mouse monoclonal anti-Ubiquitin EMD Millipore Cat#MAB1510; RRID:AB_461752
Mouse monoclonal anti-Ubiquitinylated proteins 
(FK1)
EMD Millipore Cat# 04–262; RRID:AB_11213557
Mouse monoclonal anti-Ubiquitin (FK2) EMD Millipore Cat# ST1200–100UG; RRID:AB_10681625
Rabbit polyclonal anti-K48 (Apu2) EMD Millipore Cat# 05–1307; RRID:AB_1587578
Rabbit polyclonal anti-K63 (Apu3) EMD Millipore Cat# 05–1308; RRID:AB_1587580
Rabbit polyclonal anti-pericentrin EMD Millipore Cat# ABT59; RRID:AB_10947564
Rabbit polyclonal anti-PSMA5 Thermo Fisher Cat# PA1–1962; RRID:AB_2171717
Rabbit polyclonal anti-PSMB8 Thermo Fisher Cat# PA1–972; RRID:AB_2172350
Rabbit polyclonal anti-VCP Proteintech Cat# 10736–1-AP; RRID:AB_2214635
Rabbit polyclonal anti-SQSTM Bethyl Cat# A302–856A; RRID:AB_10631138
Rabbit polyclonal anti-HDAC6 Proteintech Cat# 12834–1-AP; RRID:AB_10597094
Rabbit polyclonal anti-BAG3 Bethyl Cat# A302–806A; RRID:AB_10631035
Rabbit polyclonal anti-UBAP2L Bethyl Cat# A300–533A; RRID:AB_477953
Rabbit polyclonal anti-TRIM25 Bethyl Cat# A301–856A; RRID:AB_1279507
Phospho-eIF2alpha (Ser51) (D9G8) XP Rabbit mAb 
antibody
Cell Signaling Technology Cat# 3398; RRID:AB_2096481
Mouse Anti-alpha-Tubulin Monoclonal Antibody, 
Unconjugated, Clone DM1A
Cell Signaling Technology Cat# 3873; RRID:AB_1904178
Goat anti-Rabbit IgG (H+L) Superclonal, Alexa Fluor 
647
Thermo Fisher Cat# A27040; RRID:AB_2536101
Goat anti-Rabbit IgG (H+L) Superclonal, Alexa Fluor 
488
Thermo Fisher Cat# A27034; RRID:AB_2536097
Goat anti-Mouse IgG (H+L) Superclonal, Alexa Fluor 
647
Thermo Fisher Cat# A28181; RRID:AB_2536165
Goat anti-Mouse IgG (H+L) Superclonal, Alexa Fluor 
488
Thermo Fisher Cat# A28175; RRID:AB_2536161
Goat anti-Mouse IgG / IgM (H+L) Secondary 
Antibody, Alexa Fluor 488
Thermo Fisher Cat# A-10680; RRID:AB_2534062
Chemicals, Peptides, and Recombinant Proteins
Sodium arsenite Sigma N/A
MG132 Tocris Cat# 1748
TAK-243 / MLN7243 / Ub-E1i Chemietek Cat# CT-M7243
TAK924 / MLN4924 / N8-E1i Cayman Chemical Cat# 15217
L-LYSINE:2HCL (13C6, 99%; 15N2, 99%) Cambrige Isotope Labs Cat# CNLM-291
Deposited Data
Quantitative mass spectrometry data This paper MassIVE repository (https://massive.ucsd.edu/
ProteoSAFe/static/massive.jsp) accession 
MassIVE: MSV000082933
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REAGENT or RESOURCE SOURCE IDENTIFIER
Human Lenti-X 293T cells Clontech Cat#632180
Human HCT116 ENCODE Project N/A
Human HeLa-S3 cells Bennett Lab N/A
HEK293T G3BP1-GFP Generated in-house 
(Markmilleretal., 2018)
N/A
Software and Algorithms
CellProfiler Carpenter et al., 2006 https://cellprofiler.org/
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